Literature DB >> 29667554

Establishment of Novel Reporter Cells Stably Maintaining Transcription Factor-driven Human Secreted Alkaline Phosphatase Expression.

Riho Kurata1,2, Asuka Kumagai3, Xiaofeng Cui4, Masamitsu Harada3,5, Jun Nagai3, Yasuhiro Yoshida6, Kei-Ichi Ozaki2, Yoshimasa Tanaka3, Tomo Yonezawa3.   

Abstract

BACKGROUND: Transcriptional regulation is a very important and pivotal function in myriad biological responses. Thus, methods to determine transcriptional activity are required in not only basic medical research but also in drug discovery. We established novel reporter constructs using human secreted embryonic alkaline phosphatase (SEAP) and Epstein-Barr virus nuclear antigen (EBNA) 1, which can maintain constructs synchronized to host cell replication.
METHODS: We established nuclear factor-kappa B (NFkB) or interferon regulatory factor (IRF) driven SEAP expression constructs and then, introduced them into culture cells.
RESULTS: The cells maintain reporter constructs for a long period in the culture and produce SEAP into culture supernatant in response to each specific ligand such as lipopolysaccharide (LPS) and interferon- beta. Measuring SEAP with chemiluminescence makes it possible to get high standard dynamic range applying to high-throughput screening in drug discovery in both 96 and 384 well format. We can also use it to determine transcriptional activity in the cells transfected with expression plasmid or treated with various toll-like receptor (TLR) ligands in a concentration-dependent manner and time-dependent manner. Finally, we demonstrated drug screening using a number of natural products library.
CONCLUSION: We for the first time established the two novel reporter cells and validated their quality and accuracy enough to carry out drug screening. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  EBNA1; IRF; NFkB; SEAP; drug screening; transcription activity.

Mesh:

Substances:

Year:  2018        PMID: 29667554     DOI: 10.2174/1389201019666180418093334

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  3 in total

1.  Establishment of Novel Protein Interaction Assays between Sin3 and REST Using Surface Plasmon Resonance and Time-Resolved Fluorescence Energy Transfer.

Authors:  Masamitsu Harada; Jun Nagai; Riho Kurata; Xiaofeng Cui; Takayuki Isagawa; Hiroaki Semba; Yasuhiro Yoshida; Norihiko Takeda; Koji Maemura; Tomo Yonezawa
Journal:  Int J Mol Sci       Date:  2021-02-26       Impact factor: 5.923

2.  Establishment of Novel High-Standard Chemiluminescent Assay for NTPase in Two Protozoans and Its High-Throughput Screening.

Authors:  Masamitsu Harada; Jun Nagai; Riho Kurata; Kenji Shimizu; Xiaofeng Cui; Takayuki Isagawa; Hiroaki Semba; Jun Ishihara; Yasuhiro Yoshida; Norihiko Takeda; Koji Maemura; Tomo Yonezawa
Journal:  Mar Drugs       Date:  2020-03-13       Impact factor: 5.118

3.  Novel Reporter System Monitoring IL-18 Specific Signaling Can Be Applied to High-Throughput Screening.

Authors:  Riho Kurata; Kenji Shimizu; Xiaofeng Cui; Masamitsu Harada; Takayuki Isagawa; Hiroaki Semba; Jun Ishihara; Koji Yamada; Jun Nagai; Yasuhiro Yoshida; Norihiko Takeda; Koji Maemura; Tomo Yonezawa
Journal:  Mar Drugs       Date:  2020-01-17       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.